Brief: Observe Medical Q3 EBITDA Loss At NOK 10.7 Mln
Nov 3 (Reuters) - Observe Medical ASA OBSRV.OL :
* OBSERVE MEDICAL ASA: THIRD QUARTER 2022 RESULTS
* FOR Q3 OF 2022, OBSERVE MEDICAL REPORTED NOK 3.4 MILLION
IN
TOTAL REVENUES, AND GROSS MARGIN AMOUNTED TO 41 PER CENT
* Q3 EBITDA FOR QUARTER AMOUNTED TO NEGATIVE NOK 10.7
MILLION AS
GROUP CONTINUES TO INVEST IN LINE WITH GROWTH STRATEGY.
Source text for Eikon: ID:nWkr4xW31L
Further company coverage: OBSRV.OL
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Observe Medical ASA
See all newsBrief: Observe Medical Signs Order From Portugal
Brief: Observe Medical Announces Repeat Order For Unometer Safeti Max
Brief: Observe Medical Enters The Philippine Market
Brief: Observe Medical H1 Oper. Revenues Up At NOK 14.4 Million
Brief: Observe Medical Strengthens Position In India Through Exclusive Distribution Deal